A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.
View / Open Files
Authors
Öijerstedt, Linn
Remnestål, Julia
Olofsson, Jennie
Ullgren, Abbe
Seelaar, Harro
van Swieten, John C
Synofzik, Matthis
Sanchez-Valle, Raquel
Moreno, Fermin
Finger, Elizabeth
Masellis, Mario
Tartaglia, Carmela
Vandenberghe, Rik
Laforce, Robert
Galimberti, Daniela
Borroni, Barbara
Butler, Chris R
Gerhard, Alexander
Ducharme, Simon
Rohrer, Jonathan D
Månberg, Anna
Graff, Caroline
Nilsson, Peter
Genetic Frontotemporal Dementia Initiative (GENFI)
Publication Date
2021-11-27Journal Title
Mol Neurodegener
ISSN
1750-1326
Publisher
Springer Science and Business Media LLC
Volume
16
Issue
1
Number
ARTN 79
Pages
79
Type
Article
This Version
VoR
Physical Medium
Electronic
Metadata
Show full item recordCitation
Bergström, S., Öijerstedt, L., Remnestål, J., Olofsson, J., Ullgren, A., Seelaar, H., van Swieten, J. C., et al. (2021). A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.. Mol Neurodegener, 16 (1. ARTN 79), 79. https://doi.org/10.1186/s13024-021-00499-4
Abstract
BACKGROUND: A detailed understanding of the pathological processes involved in genetic frontotemporal dementia is critical in order to provide the patients with an optimal future treatment. Protein levels in CSF have the potential to reflect different pathophysiological processes in the brain. We aimed to identify and evaluate panels of CSF proteins with potential to separate symptomatic individuals from individuals without clinical symptoms (unaffected), as well as presymptomatic individuals from mutation non-carriers. METHODS: A multiplexed antibody-based suspension bead array was used to analyse levels of 111 proteins in CSF samples from 221 individuals from families with genetic frontotemporal dementia. The data was explored using LASSO and Random forest. RESULTS: When comparing affected individuals with unaffected individuals, 14 proteins were identified as potentially important for the separation. Among these, four were identified as most important, namely neurofilament medium polypeptide (NEFM), neuronal pentraxin 2 (NPTX2), neurosecretory protein VGF (VGF) and aquaporin 4 (AQP4). The combined profile of these four proteins successfully separated the two groups, with higher levels of NEFM and AQP4 and lower levels of NPTX2 in affected compared to unaffected individuals. VGF contributed to the models, but the levels were not significantly lower in affected individuals. Next, when comparing presymptomatic GRN and C9orf72 mutation carriers in proximity to symptom onset with mutation non-carriers, six proteins were identified with a potential to contribute to a separation, including progranulin (GRN). CONCLUSION: In conclusion, we have identified several proteins with the combined potential to separate affected individuals from unaffected individuals, as well as proteins with potential to contribute to the separation between presymptomatic individuals and mutation non-carriers. Further studies are needed to continue the investigation of these proteins and their potential association to the pathophysiological mechanisms in genetic FTD.
Keywords
Aquaporin 4 (AQP4), Cerebrospinal fluid, LASSO, Neurofilament medium polypeptide (NEFM), Neuronal pentraxin 2 (NPTX2), Neurosecretory protein VGF (VGF), Random forest, Suspension bead array
Identifiers
External DOI: https://doi.org/10.1186/s13024-021-00499-4
This record's URL: https://www.repository.cam.ac.uk/handle/1810/332828
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk